PHS
SYK icon

PFM Health Sciences’s Stryker SYK Stock Holding History

PFM Health Sciences’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.21M Sell
21,957
-28,895
-57% -$10.4M 0.66% 50
2025
Q4 		$17.9M Buy
+50,852
New +$18.5M 1.78% 20
2025
Q1 		– Sell
-32,349
Closed -$11.6M – 88
2024
Q4 		$11.6M Sell
32,349
-34,665
-52% -$12.8M 0.72% 38
2024
Q3 		$24.2M Sell
67,014
-47,283
-41% -$16.3M 1.37% 26
2024
Q2 		$38.9M Buy
114,297
+59,205
+107% +$20.1M 1.92% 16
2024
Q1 		$19.7M Sell
55,092
-3,537
-6% -$1.19M 0.93% 39
2023
Q4 		$17.6M Buy
58,629
+46,523
+384% +$13.1M 1.05% 33
2023
Q3 		$3.31M Sell
12,106
-122,916
-91% -$35.2M 0.16% 66
2023
Q2 		$41.2M Buy
+135,022
New +$39M 1.6% 29
2019
Q4 		– Sell
-207,887
Closed -$45M – 76
2019
Q3 		$45M Sell
207,887
-220,962
-52% -$47.4M 1.33% 32
2019
Q2 		$88.2M Sell
428,849
-150,595
-26% -$28.8M 1.67% 18
2019
Q1 		$114M Buy
+579,444
New +$104M 2.53% 6
2015
Q2 		– Sell
-717,374
Closed -$68M – 107
2015
Q1 		$66.2M Sell
717,374
-479,404
-40% -$44.6M 1.82% 20
2014
Q4 		$113M Buy
+1,196,778
New +$106M 2.64% 8

Other funds holding SYK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GT
Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PFM Health Sciences's SYK Position: Q1 2026 in Review

PFM Health Sciences reduced its Stryker (SYK) stake by 57% in Q1 2026, selling an estimated $10.4M and leaving 21,957 shares worth $7.21M. The position accounts for 0.66% of the portfolio, ranked #50.

PFM Health Sciences first reported a position in SYK in Q4 2014 and has held it in 14 quarters since. The position peaked at $114M in Q1 2019. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • PFM Health Sciences held 21,957 shares of Stryker worth $7.21M as of Q1 2026.
  • PFM Health Sciences sold 28,895 Stryker shares in Q1 2026, an estimated $10.4M.
  • Stryker made up 0.66% of PFM Health Sciences's portfolio in Q1 2026, its #50 holding.
  • PFM Health Sciences first reported a position in Stryker in Q4 2014 and has held it in 14 quarters since.
  • PFM Health Sciences's Stryker position peaked at $114M in Q1 2019.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.